Ehlers-Danlos Syndrome (EDS) Supportive Care Protocol

Ehlers-Danlos Syndrome (EDS) is a group of inherited connective tissue disorders caused by defects in collagen and other connective tissue proteins. The 2017 classification identifies 13 types, with hypermobile EDS (hEDS) being the most common.

TYPES OF EDS:

•Hypermobile EDS (hEDS): Most common; joint hypermobility, pain, fatigue

•Classical EDS (cEDS): Very stretchy, fragile skin; easy bruising

•Vascular EDS (vEDS): Serious - risk of arterial and organ rupture

•Kyphoscoliotic, Arthrochalasia, Dermatosparaxis, and others: Rare types

SYMPTOMS vary by type but commonly include:

•Joint hypermobility and instability

•Chronic pain (often widespread)

•Fatigue

•Easy bruising

•Stretchy or fragile skin

•Poor wound healing

•Digestive problems

•Dysautonomia (POTS)

CRITICAL: EDS requires specialized medical care. Vascular EDS can be life-threatening. This protocol is SUPPORTIVE ONLY.

MANAGEMENT INCLUDES:

•Physical therapy: Core strengthening, joint protection, proprioception

•Pain management: Multimodal approach

•Joint protection: Bracing, taping, activity modification

•Cardiovascular evaluation: Especially for vascular EDS

•POTS management: If dysautonomia present

•GI evaluation: For motility issues

* Vitamin C is essential for collagen synthesis and may theoretically support connective tissue.

* Magnesium may help with muscle cramps and pain.

* Collagen peptides are taken by many EDS patients though specific evidence is lacking.

* Omega-3s may help with chronic pain and inflammation.

Expected timeline: EDS is a lifelong condition. Supplements may provide gradual support. Physical therapy and lifestyle modifications are key to management.

Clinical Perspective

Ehlers-Danlos Syndromes: Group of heritable connective tissue disorders. 2017 classification: 13 types. Most common is hypermobile EDS (hEDS) - clinical diagnosis (2017 criteria); others have genetic tests. Classical EDS: COL5A1/2 mutations. Vascular EDS: COL3A1 mutations - arterial, intestinal, uterine rupture risk; median lifespan 50 years. Features across types: joint hypermobility (Beighton score), skin involvement (hyperextensibility, fragility, atrophic scars), tissue fragility, chronic pain, fatigue.

CRITICAL: Identify type - vascular EDS is life-threatening and requires specialized management. hEDS diagnosis is clinical (Beighton score, criteria). Genetic testing for suspected non-hEDS types. Multidisciplinary management: PT/OT for joint stability, pain management, cardiology for vascular, GI for motility. No disease-modifying treatment. Supplements are supportive; evidence specific to EDS is very limited.

* Vitamin C (C-grade): Collagen synthesis cofactor. Review: (PMID: 23075608). 1000-2000mg daily. Theoretical benefit; no EDS trials.

* Magnesium (C-grade): Muscle function. Systematic review: (PMID: 28445426). 300-400mg daily.

* Collagen Peptides (C-grade): Connective tissue support. Systematic review joint health: (PMID: 28786550). 10-15g daily. Limited EDS evidence.

* Omega-3 Fatty Acids (C-grade): Anti-inflammatory; pain. Systematic review: (PMID: 27840029). 2-4g EPA+DHA daily.

* Vitamin D (C-grade): Bone health. Review: (PMID: 28750270). 2000-4000 IU daily.

* Glucosamine (C-grade): Cartilage support. Cochrane: (PMID: 15495035). 1500mg daily.

* B-Complex (C-grade): Energy. Review: (PMID: 27450775). Daily.

* CoQ10 (C-grade): Fatigue; muscle. Review: (PMID: 26597398). 100-200mg daily.

* MSM (C-grade): Connective tissue. Review: (PMID: 26502953). 1000-3000mg daily.

Assessment targets: Beighton score, pain assessment, functional status, fatigue scales, cardiovascular screening (echo for vascular), GI symptoms.

Protocol notes: Physical therapy: cornerstone of management; strengthen muscles to stabilize joints; proprioceptive training; avoid overstretching. Pain: often chronic and widespread; multimodal approach; avoid opioids if possible; low-dose naltrexone may help some. POTS: common in hEDS; salt, fluids, compression, exercise, fludrocortisone, midodrine. GI: gastroparesis, IBS common; small frequent meals, prokinetics. MCAS: mast cell activation may co-occur; consider if allergic symptoms. Sleep: often poor; address sleep hygiene, consider sleep study. Mental health: chronic pain impacts mood; support, therapy. Pregnancy: increased complications in some types; genetic counseling. Vascular EDS: avoid invasive procedures when possible; BP control; no contact sports; celiprolol may reduce vascular events. Surgery: wound healing poor; careful surgical planning; avoid unnecessary procedures. Bracing: custom orthotics, joint supports helpful. Avoid: joint manipulation, hypermobility sports, excessive weight-bearing. Support groups: valuable for coping, information sharing.

View All Protocols